Karela Leaf (Momordica charantia leaf): Benefits, Dosage, Safety & Evidence

Questions fréquentes

How does karela leaf work in the body?

Karela leaf contains several bioactive compounds that contribute to its medicinal effects. Momordicin and charantin exhibit hepatoprotective and antiparasitic properties, while polypeptide-p and lectins may help regulate blood glucose levels. Beta-sitosterol contributes anti-inflammatory effects. These compounds work synergistically to support liver function, combat intestinal parasites, and address skin conditions through blood purification mechanisms. The evidence supporting these mechanisms is preliminary (Level C), based primarily on in vitro and animal studies rather than human clinical trials.

Can karela leaf interact with diabetes medications?

Yes, karela leaf can potentially interact with diabetes medications. The leaf contains polypeptide-p and other compounds that may lower blood glucose levels. When combined with antidiabetic medications such as insulin, metformin, or sulfonylureas, this can increase the risk of hypoglycemia (dangerously low blood sugar). Symptoms may include dizziness, confusion, sweating, and weakness. If you have diabetes and wish to use karela leaf, consult a healthcare provider for proper monitoring and possible dosage adjustments of your medications.

What is the correct dosage for karela leaf?

Traditional Ayurvedic practice recommends two primary forms of karela leaf administration. Fresh leaf juice is typically taken at 20-30ml once daily. Alternatively, dried leaf powder can be consumed at 1-3 grams twice daily. These dosages are based on traditional use rather than standardized clinical trials (Evidence Level: Traditional). Start with lower doses to assess tolerance, as the bitter compounds may cause digestive discomfort. Always consult a qualified herbalist or healthcare provider for personalized dosing recommendations.

Is karela leaf safe to take during pregnancy?

No, karela leaf is considered unsafe during pregnancy. The plant contains compounds that may stimulate uterine contractions and potentially cause miscarriage. Animal studies have demonstrated embryotoxic effects, and traditional Ayurvedic texts contraindicate its use in pregnancy. Additionally, individuals with G6PD deficiency (favism) should avoid karela leaf due to risk of hemolytic anemia. Women who are pregnant, planning pregnancy, or breastfeeding should avoid karela leaf entirely. Consult a healthcare provider for safe alternatives during pregnancy.

What are the benefits of karela leaf for liver health?

Karela leaf has been used traditionally in Ayurveda for supporting liver health and treating liver conditions. The leaf contains momordicin and charantin, compounds that exhibit hepatoprotective properties in preclinical studies. Traditional practitioners use it for liver detoxification and as a blood purifier. However, human clinical evidence is limited (Evidence Level C), with most data coming from animal and in vitro research. While promising, more rigorous human studies are needed to confirm these hepatoprotective benefits. Consult a healthcare provider before using karela leaf for liver conditions.

Fiche d'information compilée à partir de PubMed

Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.

Compilé à partir de 26 articles PubMed · modèle : gemma4:31b

Résumé

Momordica charantia leaf extracts demonstrate significant antioxidant, anti-inflammatory, and anticancer properties in various in vitro and animal models [PMID:34073706, 28510957, 20731662].

Contexte

Momordica charantia, commonly known as bitter melon, snake fruit, or Saint Vincent's herb, is a species found in tropical and subtropical biomes, including Brazil [PMID:38440938].

Usages traditionnels

The plant is widely consumed as a vegetable and used as folk medicine in Asia [PMID:20731662] and is traditionally employed to treat a wide number of diseases [PMID:42106488], including diabetes-related disorders [PMID:42160833] and fevers in South India [PMID:22433533].

Composés actifs

Identified compounds include linalool (major volatile compound) [PMID:38440938], cucurbitane triterpenoids such as 5β,19-epoxycucurbita-6,23-diene-3β,19,25-triol and 3β,7β,25-trihydroxycucurbita-5,23-dien-19-al [PMID:27058519], charantadiol A [PMID:34577123], Kuguacin J [PMID:22266361], and flavonoids/phenolics including rutin, gentistic acid, o-coumaric acid, 6"-O-acetylastragalin, afzelin, momordicoside E, naringenin, and prunin [PMID:19723180, 42160833].

Mécanisme d'action

Mechanisms include the inhibition of P-glycoprotein (P-gp) to reverse multidrug resistance [PMID:21414769], induction of G1 arrest and apoptosis via p53-dependent pathways and reduction of survivin in prostate cancer cells [PMID:21429659, 22266361], inhibition of MMP-2, MMP-9, and uPA secretion [PMID:20731662], and suppression of NF-κB and MAPK activation to reduce pro-inflammatory cytokines like IL-8, IL-1β, and TNF-α [PMID:26098998, 42278477].

Preuves cliniques

Preuve DObesity and Lipid Metabolism

Distilled water extract of M. charantia leaf (200 mg/kg/d) in HFD-fed mice reduced body weight, lipid accumulation, and adipose tissue volume, while improving glucose tolerance and insulin resistance [PMID:34073706].

Preuve DProstate Cancer

Leaf extract and Kuguacin J inhibited migration and invasion of rat prostate cancer cells in vitro and in vivo [PMID:20731662, 22266361].

Preuve DSkin Inflammation (Acne)

Total phenolic extract of wild bitter melon leaf attenuated P. acnes-induced ear swelling and microabscesses in mice [PMID:26098998, 32961947].

Preuve DPeriodontal Inflammation

Charantadiol A from leaf extract suppressed P. gingivalis-induced IL-6 and IL-8 in THP-1 cells and a mouse model [PMID:34577123, 27058519].

Preuve DDiabetes

Ethyl acetate fraction showed inhibitory activity against alpha-amylase and alpha-glucosidase in vitro [PMID:42160833].

Synthèse des preuves

The evidence is primarily based on in vitro studies and animal models (Level D), demonstrating strong potential for anti-inflammatory, antioxidant, and anticancer activities, though human clinical trials are lacking in the provided data.

Sources PubMed

1.PMID: 38370168 (2024) — Different particle sizes of Momordica charantia leaf powder modify the rheological and textural properties of corn starch-based 3D food printing ink. · Heliyon
2.PMID: 34073706 (2021) — Comparative Analysis of Metabolite Profiling of Momordica charantia Leaf and the Anti-Obesity Effect through Regulating Lipid Metabolism. · International journal of environmental research and public health
3.PMID: 38440938 (2025) — Determination of the volatile chemical profile of Momordica charantia (bitter melon) leaf and fruit by GC-MS. · Natural product research
4.PMID: 28510957 (2014) — Antioxidant, cell-protective, and anti-melanogenic activities of leaf extracts from wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) cultivars. · Botanical studies
5.PMID: 37504854 (2023)

Karela Leaf

Sources et citations

Calculer une dose sûre de Karela Leaf